Novartis suffers no equity hangover for long bonds
A plunge in global stock prices at the start of the week only closed the European investment grade corporate bond market for a day before Novartis attracted €6.5bn of combined demand for a triple tranche offering.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: